Vir Biotechnology Inc (VIR)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,398,810 | 1,919,060 | 2,802,090 | 1,954,270 | 918,761 |
| Total stockholders’ equity | US$ in thousands | 1,150,380 | 1,590,240 | 2,077,960 | 1,431,850 | 716,852 |
| Financial leverage ratio | 1.22 | 1.21 | 1.35 | 1.36 | 1.28 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,398,810K ÷ $1,150,380K
= 1.22
The financial leverage ratio of Vir Biotechnology Inc has shown some fluctuations over the past five years. It stood at 1.28 in December 31, 2020, and increased slightly to 1.36 by December 31, 2021. The ratio then decreased to 1.35 by December 31, 2022, followed by a more notable drop to 1.21 by December 31, 2023. Subsequently, the ratio increased slightly to 1.22 by December 31, 2024.
Overall, the company's financial leverage ratio reflects a moderate level of leverage, indicating that it relies on a combination of debt and equity to finance its operations and investments. The fluctuations in the ratio over the years suggest some changes in the capital structure of the company and its ability to meet financial obligations. It is important for Vir Biotechnology Inc to carefully manage its leverage to ensure financial stability and growth in the long term.
Peer comparison
Dec 31, 2024